GlassScriptPhysician profile
Melissa Radcliffe
NPI 1992356240
$1,506.89
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $504 · 2022: $614 · 2023: $327 · 2024: $62.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $389.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $630.26 | 2021-2024 | |
| Indivior INC. | $159.54 | 2021-2023 | Sublocade |
| Janssen Pharmaceuticals, INC | $116.27 | 2021-2023 | Spravato, Invega Sustenna |
| Otsuka America Pharmaceutical, INC. | $111.98 | 2022-2023 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $69.47 | 2021-2022 | |
| Alkermes, INC. | $61.64 | 2023-2024 | Lybalvi |
| Axsome Therapeutics, INC. | $49.46 | 2023 | Sunosi, Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $34.56 | 2023 | Trintellix |
| Baxter Healthcare | $34.46 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $31.55 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $30.61 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $29.14 | 2023 | Austedo |
| Lilly USA, LLC | $26.07 | 2021 | |
| Ironshore Pharmaceuticals INC. | $19.92 | 2023 | Jornay Pm |
| Uswm, LLC | $18.55 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noven Therapeutics, LLC | $18.27 | 2024 | Secuado |
| Hikma Pharmaceuticals USA | $18.00 | 2021 | |
| Idorsia Pharmaceuticals US INC | $16.90 | 2023 | Quviviq |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.30 | 2023 | |
| Virtus Pharmaceuticals LLC | $14.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Radcliffe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.